As platinum-based chemotherapy is among the most utilised chemotherapeutic treatment strategies in lung cancer, we examined the impact of SASH1 depletion on the cellular sensitivity of NSCLC cell lines to cisplatin. The gene discussed is SASH1; the disease is non-small cell lung carcinoma.